FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis

被引:451
作者
Andreu, Pauline [1 ]
Johansson, Magnus [1 ]
Affara, Nesrine I. [1 ]
Pucci, Ferdinando [3 ,4 ]
Tan, Tingting [1 ]
Junankar, Simon [1 ]
Korets, Lidiya [1 ]
Lam, Julia [1 ]
Tawfik, David [1 ]
DeNardo, David G. [1 ]
Naldini, Luigi [3 ,4 ]
de Visser, Karin E. [5 ]
De Palma, Michele [3 ,4 ]
Coussens, Lisa M. [1 ,2 ]
机构
[1] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[3] San Raffaele Telethon Inst Gene Therapy, Angiogenesis & Tumor Targeting Res Unit, I-20132 Milan, Italy
[4] Univ Vita Salute San Raffaele, San Raffaele Inst, I-20132 Milan, Italy
[5] Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands
基金
美国国家卫生研究院; 瑞典研究理事会;
关键词
K14-HPV16 TRANSGENIC MICE; MAST-CELLS; TIE2-EXPRESSING MONOCYTES; HUMORAL IMMUNITY; PRIMARY TUMORS; CANCER; MACROPHAGES; GROWTH; ANGIOGENESIS; RECEPTORS;
D O I
10.1016/j.ccr.2009.12.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chronically activated leukocytes recruited to premalignant tissues functionally contribute to cancer development; however, mechanisms underlying pro- versus anti-tumor programming of neoplastic tissues by immune cells remain obscure. Using the K14-HPV16 mouse model of squamous carcinogenesis, we report that Bcells and humoral immunity foster cancer development by activating Fc gamma receptors (Fc gamma Rs) on resident and recruited myeloid cells. Stromal accumulation of autoantibodies in premalignant skin, through their interaction with activating Fc gamma Rs, regulate recruitment, composition, and bioeffector functions of leukocytes in neoplastic tissue, which in turn promote neoplastic progression and subsequent carcinoma development. These findings support a model in which B cells, humoral immunity, and activating Fc gamma Rs are required for establishing chronic inflammatory programs that promote de novo carcinogenesis.
引用
收藏
页码:121 / 134
页数:14
相关论文
共 39 条
[1]   PROGRESSIVE SQUAMOUS EPITHELIAL NEOPLASIA IN K14-HUMAN PAPILLOMAVIRUS TYPE-16 TRANSGENIC MICE [J].
ARBEIT, JM ;
MUNGER, K ;
HOWLEY, PM ;
HANAHAN, D .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4358-4368
[2]  
Arbeit JM, 1996, ONCOGENE, V13, P1847
[3]   B lymphocyte pathology in human colorectal cancer. Experimental and clinical therapeutic effects of partial B cell depletion [J].
Barbera-Guillem, E ;
Nelson, MB ;
Barr, B ;
Nyhus, JK ;
May, KF ;
Feng, L ;
Sampsel, JW .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 48 (10) :541-549
[4]  
Barbera-Guillem Emilio, 1999, Neoplasia (New York), V1, P453, DOI 10.1038/sj.neo.7900054
[5]   Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung [J].
Baumann, U ;
Chouchakova, N ;
Gewecke, B ;
Köhl, J ;
Carroll, MC ;
Schmidt, RE ;
Gessner, JE .
JOURNAL OF IMMUNOLOGY, 2001, 167 (02) :1022-1027
[6]   FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis [J].
Bergtold, Amy ;
Gavhane, Anamika ;
D'Agati, Vivette ;
Madaio, Michael ;
Clynes, Raphael .
JOURNAL OF IMMUNOLOGY, 2006, 177 (10) :7287-7295
[7]  
Brandtzaeg P, 2006, ADV EXP MED BIOL, V579, P149
[8]   IMMUNOGLOBULIN GENE REARRANGEMENT IN B-CELL DEFICIENT MICE GENERATED BY TARGETED DELETION OF THE J(H) LOCUS [J].
CHEN, JZ ;
TROUNSTINE, M ;
ALT, FW ;
YOUNG, F ;
KURAHARA, C ;
LORING, JF ;
HUSZAR, D .
INTERNATIONAL IMMUNOLOGY, 1993, 5 (06) :647-656
[9]   Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis [J].
Coussens, LM ;
Raymond, WW ;
Bergers, G ;
Laig-Webster, M ;
Behrendtsen, O ;
Werb, Z ;
Caughey, GH ;
Hanahan, D .
GENES & DEVELOPMENT, 1999, 13 (11) :1382-1397
[10]  
Coussens LM, 1996, AM J PATHOL, V149, P1899